Turbine.ai pioneers the use of Simulated Cells™ technology to unlock cures, identify the best treatment responders, and rationalize the R&D process in drug discovery, transcending traditional limitations by simulating tumor cell behavior prior to wet lab experiments.
Turbine.ai pioneers the use of Simulated Cells™ technology to unlock cures, identify the best treatment responders, and rationalize the R&D process in drug discovery, transcending traditional limitations by simulating tumor cell behavior prior to wet lab experiments.
Cleerlyhealth
"Cleerly is a digital healthcare entity revolutionizing heart disease treatment through a clinically-endorsed, AI-integrated digital care platform, which leverages coronary computed tomography angiography (CCTA) imaging to accurately detect and delineate atherosclerosis at an early stage, facilitating personalized, life-saving treatment plans for patients throughout their healthcare journey."
Atomwise
Atomwise harnesses the power of AI to revolutionize small molecule drug discovery, striving to tackle challenging targets to streamline the drug development process, enabling a quicker path to potential treatments.
Recursion
Recursion leverages technology to create virtuous learning cycles around datasets, aiming to industrialize drug discovery and radically improve lives by decoding complex biology. This next-generation biopharmaceutical company combines hardware, software, and data to reshape the traditional drug discovery funnel.
Icarbonx
iCarbonX aims to unlock biological insights through multi-omics research, data integration, and machine intelligence, propelling scientific discoveries in life science and healthcare, and accelerating innovations in disease prevention, diagnosis, and treatment.
Deep Genomics
Deep Genomics harnesses artificial intelligence to revolutionize RNA therapies for a multitude of genetic conditions, standing at the cusp of drug development innovation driven by AI, RNA biology, and automation.
Mysense.ai
Turbine.ai pioneers the use of Simulated Cells™ technology to unlock cures, identify the best treatment responders, and rationalize the R&D process in drug discovery, transcending traditional limitations by simulating tumor cell behavior prior to wet lab experiments.
Caption Care
Caption Care, powered by Caption AI from Caption Health, utilizes ultrasound technology combined with artificial intelligence to enable early heart disease detection, aiming for timely intervention and personalized care pathways.
Owkin
"Owkin operates as a full-stack AI biotech entity, leveraging artificial intelligence to comprehend complex biology, which in turn aids in identifying novel treatments, accelerating and de-risking clinical trials, and developing diagnostic tools to lessen the time to impact for patients"
Tempus
"Tempus provides AI-enabled solutions that generate actionable insights from radiology images to aid healthcare providers in making more informed diagnostic and treatment decisions"
Caption Care
"Caption Care is focused on early disease detection, particularly leveraging ultrasound technology combined with artificial intelligence to enable a more accessible and accurate diagnosis process in the healthcare sector"